Delivery Order SPE2DB24D2100-SPE2DB24FBCZS

Award Date 8/14/24
Potential Completion Date 8/15/24
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,405.80, is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of May 14, 2025. There is no set-aside designation, indicating open competition. AmerisourceBergen...
This federal contract award, issued by the Defense Logistics Agency (DLA) Troop Support Medical, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $1,138.61 firm fixed price delivery order is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a prescription medication. The contract has no set-aside designation and is part of a larger indefinite delivery contract (IDC) between DLA and...
The U.S. government agency, the Defense Logistics Agency (DLA) Troop Support Medical, awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract, valued at $1,232.22, is for the provision of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product. The contract has an ultimate completion date of April 8, 2024 and does not have a set-aside designation. AmerisourceBergen Drug Corp holds a larger indefinite...
The U.S. Department of Defense's Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $1,225.44 firm fixed price delivery order to provide NOVOLOG 100 UNIT/ML FLEXPEN 3ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $7,806.25 firm fixed-price delivery order is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product. The contract has an ultimate completion date of October 18, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply NOVOLOG 100 UNIT/ML FLEXPEN 3ML. The order has a firm fixed price of $3,914.91 and an ultimate completion date of August 2, 2024. This is not a set-aside contract. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to provide a wide range of medical...
This federal contract award, valued at $2,424.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a medical supply product, with a performance period running through March 17, 2025. The contract is structured as a Firm Fixed Price Delivery Order, without any set-aside designation. Amerisourcebergen holds a significant...
This federal contract award, valued at $36,010.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a medical product, with an ultimate completion date of April 7, 2025. This is a delivery order contract with a firm fixed price pricing type. The contract was not set aside for any specific business category. Amerisourcebergen...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide NOVOLOG 100 UNIT/ML FLEXPEN 3ML pharmaceuticals. The contract has a potential value of $1,225.44 and a completion date of February 7, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is not associated with any set-aside program. In addition to this specific award, Amerisourcebergen...
This federal contract award, valued at $2,076.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a medical product. This contract is a delivery order and has a firm fixed price pricing type. The contract has an ultimate completion date of April 2, 2025. This contract is not designated as a set-aside. Amerisourcebergen Drug...
  • SPE2DB24D2100
    Indefinite Delivery Contract
  • SPE2DB24D2100-SPE2DB24FBCZS
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML products. The firm-fixed-price Delivery Order, valued at $1,893.84, has an ultimate completion date of August 15, 2024. This contract does not have a set-aside designation. Amerisourcebergen, through its Corporate Office division, is a significant supplier of pharmaceutical and medical products to various government agencies, including DLA Troop Support Medical. The company holds several Indefinite Delivery Contracts (IDCs) with the DLA and Department of Justice Federal Bureau of Investigation, collectively valued at up to $1,749,999,999, to provide a comprehensive range of critical medical commodities to support military, veterans, and other federal healthcare programs.

Generated 11/13/24, 9:08 AM